Ulrich Bartke Appointed to New Position of Vice President Global Sales & Marketing of Inyx
- Will Direct Intensified Sales Growth and Strategic Marketing Initiatives - NEW YORK, May 27 /PRNewswire-FirstCall/ -- Inyx, Inc. (OTC Bulletin Board: IYXI), an emerging specialty pharmaceutical company with a focus on niche drug delivery technologies and products, announced today that Ulrich Bartke, Ph.D. will be joining the company on June 1, 2004 in the newly established, senior management position of Vice President Global Sales & Marketing.
"Initially, Mr. Bartke
will focus on building Inyx's contract manufacturing revenues and increasing the utilization of production capacity, with the objective to increase sales and profitability," Dr. Kachkar informed.
"I am very pleased to be joining Inyx
," said Mr. Bartke
has niche aerosol pharmaceutical development and production expertise that is needed in the marketplace today, particularly the proven ability to develop and produce non-ozone-depleting aerosol products.I am looking forward to assisting in the growth of Inyx's
will be based initially at the company's development and production center located in Cheshire, England, operated under its wholly owned subsidiary INyX Pharma Limited.He will be directing the company's sales and marketing activities around the world, including in North America, Latin and South America and Asia as well as Europe. Ulrich Bartke, Ph.D. From 2001 to 2003, Mr. Bartke served as Vice President Global Sales & Marketing of PowderJect Pharmaceuticals Plc, where he directed sales growth from approximately $40 million to in excess of $290 million during his two- year tenure.
In June 2003, PowderJect
, at the time a publicly owned company traded on the London Stock Exchange, was acquired by Chiron Corporation
.Following this acquisition, Mr. Bartke became a consultant to the pharmaceutical industry, focusing on U.S. and European markets.Mr. Bartke began his professional career and served for 17 years, from 1984 to 2001, with GlaxoSmithKline companies in a number of different executive capacities.He started out in manufacturing management positions before moving into several marketing directorships at SmithKline Beecham Pharmaceuticals.In his last position, he served as Therapy Area Director, Vaccines, for GSK Pharmaceuticals Europe.Mr. Bartke holds a BSc in Pharmacy and a Ph.D. in Pharmaceutical Chemistry from the University of Berlin.